SEC Clinical Research — Andalusia, Alabama

SEC Clinical Research is a clinical research site located in Andalusia, Alabama, United States 36420.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

SEC Clinical Research has participated in 8 clinical trials with 3 currently active.

Therapeutic areas: Cardiovascular Disease and Lipoprotein(a), Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease.

Sponsors: Novartis Pharmaceuticals, Galecto Biotech AB, Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Andalusia

Browse all research sites in Alabama · View every site in Andalusia

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SEC Clinical Research?

SEC Clinical Research has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SEC Clinical Research conducted?

SEC Clinical Research has 8 clinical trials on record, with 3 currently active. Their work covers Cardiovascular Disease and Lipoprotein(a), Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease.

Is SEC Clinical Research accredited by Crixeo Clinical Trials?

SEC Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SEC Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.